Objective: The fetal inflammatory response syndrome (FIRS) is associated with impending onset of preterm labor/ delivery, microbial invasion of the amniotic cavity and increased perinatal morbidity. FIRS has been defined by an elevated fetal plasma interleukin (IL)-6, a cytokine with potent effects on the differentiation and proliferation of hematopoietic precursors. The objective of this study was to characterize the hematologic profile of fetuses with FIRS. Study design: Fetal blood sampling was performed in patients with preterm prelabor rupture of membranes and preterm labor with intact membranes (ns152). A fetal plasma IL-6 concentration G11 pg/mL was used to define FIRS. Hemoglobin concentration, platelet count, total white blood cell (WBC) count, differential count, and nucleated red blood cell (NRBC) count were obtained. Since blood cell count varies with gestational age, the observed values were corrected for fetal age by calculating a ratio between the observed and expected mean value for gestational age. Results: 1) The prevalence of FIRS was 28.9% (44/152); 2) fetuses with FIRS had a higher median corrected WBC and corrected neutrophil count than those without FIRS (WBC: median 1.4, range 0.3-5.6, vs. median 1.1, range 0.4-2.9, Ps0.001; neutrophils: median 3.6, range 0.1-57.5, vs. median 1.8, range 0.2-13.9, P-0.001); 3) neutrophilia (defined as a neutrophil count )95 th centile of gestational age) was significantly more common in fetuses with FIRS than in those without FIRS (71%, 30/42, vs. 35%, 37/105; P-0.001); 4) more than two-thirds of fetuses with FIRS had neutrophilia, whereas neutropenia was present in only 4.8% (2/42); 5) FIRS was not associated with detectable changes in hemoglobin concentration, platelet, lymphocyte, monocyte, basophil or eosinophil counts; and 6) fetuses with FIRS had a median corrected NRBC count higher than those without FIRS. However, the difference did not reach statistical significance (NRBC median 0.07, range 0-1.3, vs. median 0.04, range 0-2.3, Ps0.06).
Hemoglobin concentration, platelet count, total white blood cell (WBC) count, differential count, and nucleated red blood cell (NRBC) count were obtained. Since blood cell count varies with gestational age, the observed values were corrected for fetal age by calculating a ratio between the observed and expected mean value for gestational age. Results: 1) The prevalence of FIRS was 28.9% (44/152); 2) fetuses with FIRS had a higher median corrected WBC and corrected neutrophil count than those without FIRS (WBC: median 1.4, range 0.3-5.6, vs. median 1.1, range 0.4-2.9, Ps0.001; neutrophils: median 3.6, range 0.1-57.5, vs. median 1.8, range 0.2-13.9, P-0.001); 3) neutrophilia (defined as a neutrophil count )95 th centile of gestational age) was significantly more common in fetuses with FIRS than in those without FIRS (71%, 30/42, vs. 35%, 37/105; P-0.001); 4) more than two-thirds of fetuses with FIRS had neutrophilia, whereas neutropenia was present in only 4.8% (2/42); 5) FIRS was not associated with detectable changes in hemoglobin concentration, platelet, lymphocyte, monocyte, basophil or eosinophil counts; and 6) fetuses with FIRS had a median corrected NRBC count higher than those without FIRS. However, the difference did not reach statistical significance (NRBC median 0.07, range 0-1.3, vs. median
Introduction
The fetal inflammatory response syndrome (FIRS) was originally described in patients with spontaneous preterm labor and preterm prelabor rupture of membranes (PROM) and defined by fetal plasma interleukin (IL)-6 concentrations G11 pg/mL w58, 62, 148x. FIRS is also associated with an increase in fetal plasma concentrations of soluble tumor necrosis factor receptors-1 and -2, IL-1b, 131, 140, 149, 154, 155, 177, 198x . FIRS is associated with the impending onset of preterm labor/ delivery, microbial invasion of the amniotic cavity and increased perinatal morbidity after adjustment for gestational age w31, 78, 89, 90, 92, 142, 147, 178, 186, 189, 193, 196, 197, 199x .
A solid body of evidence supports the view that intraamniotic infection/inflammation plays a major role in the pathophysiology of FIRS w59, 86, 112, 127, 129, 141, 143, 196x . Fetuses with FIRS had a higher rate of severe neonatal morbidity (e.g., respiratory distress syndrome w58x, suspected or proven neonatal sepsis w58, 196x, pneumonia w58x, bronchopulmonary dysplasia w81, 82, 178, 193, 197x , intraventricular hemorrhage w58x, periventricular leukomalacia w199x, cerebral palsy w7, 9, 31-33, 90, 191, 199x , and necrotizing enterocolitis w58, 155x). FIRS is considered the fetal counterpart of the systemic inflammatory response syndrome (SIRS) seen in adults w113, 137x. Intra-amniotic infection/ inflammation, which is characterized by changes in amniotic fluid concentrations of several proinflammatory cytokines w84, 100, 124, 138, 145, 148, 150, 151x, anti-inflammatory cytokines w61x, chemokines w27, 39, 46, 67, 111, 115, 146x , caspase-1 (a component of an inflammasome) w60x, antimicrobial peptides w41, 45, 163x, hemostatic factors w42, 43x, complement activation products w164, 175x, soluble pattern recognition receptor (pantraxin) w29x, damage-associated molecular patterns and their receptors w13, 25, 52, 139, 144x, protease-antiprotease w70x, adipocytokines w85, 107, 108, 174x, surfactant proteins w26x, angiogenic factors w3, 123x, and matrix-degrading enzymes w49, 50, 101-106, 112, 127-129x, is therefore a strong risk factor for short-and long-term neonatal complications w18, 73, 76, 182, 188, 191, 192, 194-196x. Changes in hematologic parameters have been observed in patients with SIRS w1, 24, 53, 65, 80, 95x. Indeed, either leukocytosis wwhite blood cell (WBC) count )12,000/mLx or leukopenia (WBC -4000/mL) is one of the criteria for the diagnosis of SIRS. Either leukocytosis or leukopenia is associated with a poor outcome w4, 64, 179x. In adults, an increased total WBC or neutrophil count is an indicator of subclinical inflammation w19, 51, 64, 98, 179x. In neonates, neutrophilia is associated with respiratory distress syndrome w120, 121, 126, 156x, early-onset neonatal sepsis w97, 157x, and cerebral injury w130, 184, 195x. Similarly, an elevated nucleated red blood cell (NRBC) count has been observed in newborns with low umbilical arterial pH w6, 15, 68x, intrauterine growth restriction w5, 6, 10, 110x, early-onset neonatal seizures w16, 40, 72x, cerebral white matter injury w20, 88, 160x, and infants who develop cerebral palsy w135, 170x. Indeed, an abnormal NRBC count at birth is associated more strongly with short-term neonatal outcome (requirement of mechanical ventilation, need for vasopressure agents, or neonatal mortality) than birth weight or gestational age regardless of being small or appropriate for gestational age w110x.
An increased NRBC count has been associated with chronic intrauterine hypoxia or stress w8, 17, 66, 77, 99, 134, 158, 168, 183x , frequently seen in fetuses of mothers with preeclampsia w2, 5, 159, 161x, intrauterine growth restriction w5, 6, 10, 110x, or diabetes mellitus w38, 63, 187x. However, an experimental study indicates that the administration of recombinant IL-6 to animals can stimulate the erythroid progenitor cells in the bone marrow and eventually lead to the release of NRBC into circulation, suggesting that inflammation can trigger systemic elevation of NRBC count w173x.
Similarly, in patients with preterm labor and preterm PROM, histologic chorioamnionitis or severe acute placental inflammation are associated with an increased neonatal NRBC count w87, 135, 153x, suggesting that intrauterine infection may modulate hematopoiesis in neonates and/or fetuses.
The objective of this study was to determine if FIRS is associated with changes in the fetal hematologic profile.
Patients and methods

Patients and eligibility
This retrospective cross-sectional study included women who were admitted at Hutzel Hospital with preterm labor and intact membranes or with preterm PROM between March 1992 and March 1996. They were offered amniocentesis for the diagnosis of intraamniotic infection and assessment of fetal lung maturity. Patients who consented to have an amniocentesis were asked to participate in a research management protocol that included the collection of additional amniotic fluid for research purposes and cordocentesis. Criteria for eligibility into this study included 1) preterm labor with intact membranes or with preterm PROM, 2) written informed consent to have amniocentesis and cordocentesis, and 3) availability of skilled medical staff to perform amniocentesis and cordocentesis. Exclusion criteria were 1) clinical chorioamnionitis, 2) multiple gestation, 3) fetal distress, or 4) significant vaginal bleeding. Oligohydramnios was not an exclusion criterion.
Clinical definition
The diagnosis of preterm labor was made in the presence of regular uterine contractions (at least 3 in 30 min) and documented cervical change in patients with a gestational age of 20-36 6/7 weeks. Preterm PROM was diagnosed with sterile speculum examination with a combination of vaginal pooling and nitrazine and ferning tests. Intra-amniotic infection was defined as a positive microbiological culture in amniotic fluid. Clinical chorioamnionitis was diagnosed in the presence of a temperature elevation to 37.88C or higher and two or more of the following criteria: uterine tenderness, malodorous vaginal discharge, fetal tachycardia (fetal heart rate )160 beats/ min), and maternal leukocytosis (leukocyte count )15,000/mL) w55, 56x.
Since blood cell count varies with gestational age, the observed values were corrected for fetal age by calculating a ratio between the observed and expected mean value for gestational age. The reference ranges for each gestational age of fetal hemoglobin concentrations, NRBC, WBC, and platelet counts were obtained from previous studies w34, 117, 119, 176x. The corrected eosinophil and basophil counts were not obtained since they do not change with gestational age w34x. Neutrophilia was defined as a neutrophil count )95 th centile of gestational age and neutropenia was defined as a neutrophil count -5 th centile of gestational age w34x. The results of NRBC count were reported as count per 100 WBC.
All patients provided written informed consent before the performance of procedures and collection of samples. The collection and utilization of the samples for research was approved by the Human Investigation Committee of Wayne State University (Detroit, MI, USA) and the Institutional Review Board of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (National Institutes of Health, Department of Health and Human Services). Many of these samples have been used in previous studies. 
Amniocentesis, cordocentesis and assays for IL-6
All patients had a detailed ultrasonographic examination before amniocentesis and cordocentesis were performed. Electronic fetal monitoring was performed before and after the procedure to evaluate fetal well-being. Amniocentesis and cordocentesis procedures were performed under ultrasound guidance with the ''free-hand technique'' as previously described w118x. Gram stain and microbial cultures for aerobic and anaerobic bacteria and mycoplasmas were performed in amniotic fluid. The results of these tests were used for subsequent clinical management. Fetal blood was collected in EDTA. Kleihauer-Betke stains were performed on fetal blood, and all specimens were found to be free of maternal blood. Fetal blood was analyzed for hemoglobin concentration, platelet and NRBC count, as well as WBC and differential count, including neutrophils, monocytes, lymphocytes, basophils, and eosinophils. The hemoglobin concentration, platelet, and total nucleated cell count (WBC and NRBC counts) were obtained with a Coulter S-Plus IV (Coulter Electronics, Hialeah, FL, USA) analyzer. The blood films were stained by Giemsa-Wright method. The nucleated red cell and the differential leukocyte counts were determined by morphological classification of 100 cells.
Fetal plasma IL-6 concentrations were determined with commercially available ELISA (R&D Systems, Minneapolis, MN, USA). The sensitivity of the assay was 0.06 pg/mL. The intra-assay and inter-assay coefficients of variation were 3.3% and 8.3%, respectively. The results of IL-6 concentrations in fetal plasma reported herein were neither available nor used for clinical decision-making.
Statistical analysis
The Kolmogorov-Smirnov test and Shapiro-Wilk test were used to determine if the data were normally distributed. A two-tailed MannWhitney U-test was used to compare continuous nonparametric variables. Comparisons between proportions were performed using x 2 or Fisher's exact tests. Correlation between fetal plasma IL-6 concentrations and fetal hematologic parameters was determined using Spearman rank correlation test. A P-value -0.05 was considered statistically significant. Analysis was performed with SPSS, version 15 (SPSS, Chicago, IL, USA).
Results
Demographic and clinical characteristics
This study included 152 women, of which 102 (67%) presented with preterm labor and intact membranes and 50 (33%) presented with preterm PROM. Seventy-nine percent (121/152) delivered at -37 weeks of gestation. The prevalence of intra-amniotic infection and FIRS was 27% (41/152) and 28.9% (44/152), respectively. FIRS was diagnosed more frequently in patients with preterm PROM than in those with preterm labor wpreterm PROM 42%, (21/50), vs. preterm labor 22%, (23/102); Ps0.01x. Patients with FIRS had a higher rate of intra-amniotic infection, clinical chorioamnionitis, and preterm delivery than those without FIRS (all P-0.05, see Table 1 ). There was no significant difference in the frequency of exposure to antenatal steroids, tocolysis (magnesium sulfate, indomethacin, or terbutaline), or antibiotics before cordocentesis between patients with and without FIRS (all P)0.05; see Table 1 ). All patients, except five (97%), had information on hemoglobin concentrations, platelet, NRBC, and differential WBC counts.
FIRS is associated with leukocytosis and neutrophilia
Fetuses with FIRS have a higher median total WBC count and corrected WBC count for gestational age than those without FIRS (total WBC: FIRS median 6.3=10 Similarly, the median absolute and corrected neutrophil counts were higher in fetuses with FIRS than in those without FIRS (median absolute neutrophil count: 2.8=10
9 /L; median corrected neutrophil count 3.6, range 0.1-57.5, vs. 1.8, range 0.2-13.9, all P-0.05; see Table 2 , Figure 2 ). Neutro- philia was significantly more common in fetuses with FIRS than in those without FIRS w71%, (30/42), vs. 35%, (37/104), P-0.001; Table 2x . However, neither the prevalence of neutropenia w4.8%, (2/42), vs. 7.7%, (8/105), P)0.05; Table 2x nor the median lymphocyte, monocyte, eosinophil, and basophil counts were significantly different between fetuses with and without FIRS (all P)0.05, Table 2 ).
Fetuses with FIRS had a tendency of enhanced erythropoiesis
Fetuses with FIRS have a median absolute fetal NRBC count higher than those without FIRS (FIRS: median 0.5/100 WBC, range 0-14/100 WBC, vs. without FIRS: median 0.3/ 100 WBC, range 0-14/100 WBC, Ps0.01). The median /L, range 0.1-7.2=10 9 /L; median for corrected neutrophil count 3.6, range 0.1-57.5, vs. 1.8, range 0.2-13.9, all P-0.05). The y-axis is depicted in log scale. FIRSsfetal inflammatory response syndrome.
fetal NRBC count corrected for gestational age in FIRS was higher than that in fetuses without FIRS. However, the difference did not reach statistical significance (FIRS: median 0.07, range 0-1.3, vs. without FIRS: median 0.04, range 0-2.3, Ps0.06; see Table 2 and Figure 3) . The median hemoglobin concentration and platelet count were not significantly different between fetuses with and without FIRS (all P)0.05, Table 2 ).
Correlation between fetal blood IL-6 concentration and fetal blood hematologic parameters
The absolute and corrected fetal WBC counts were correlated with fetal plasma IL-6 concentrations (Spearman rs0.2, Ps0.004; Spearman rs0.3; P-0.001, respectively). Among the various WBC lineages, only the absolute and corrected neutrophil counts were correlated with an elevated fetal plasma IL-6 concentration (Spearman rs0.2 for both; Ps0.01 and 0.006, respectively). There was a significant relationship between fetal plasma IL-6 concentration and both absolute and corrected NRBC counts (Spearman rs0.3 for both; P-0.001 and Ps0.001, respectively).
Discussion
Principal findings of the study 1) Fetuses with FIRS had a higher median total WBC and neutrophil count than those without FIRS; 2) more than twothirds of fetuses with FIRS had neutrophilia, while neutropenia was present in only 4.8%; 3) FIRS was not associated with significant changes in hemoglobin concentration, platelet, lymphocyte, monocyte, basophil, or eosinophil counts; and 4) there was a tendency for fetuses with FIRS to have an elevated NRBC count when compared with those without FIRS after adjustment for gestational age.
More than two-thirds of fetuses with FIRS have neutrophilia Neutrophils are part of the innate immune system and play a critical role in the acute inflammatory response and host defense against infection. During human fetal development, neutrophils first appear in the clavicular bone marrow at 12-13 weeks of gestation w162x. However, the lymphocyte is the predominant WBC type in the preterm fetus w36x. After 32 weeks of gestation, the proportion of neutrophils increases to become the predominant leukocyte at term w34, 36x. It is interesting that while hematopoiesis in the fetal liver is characterized by proliferation of erythrocytes rather than neutrophils, the early bone marrow behaves differently -hypocellular for erythrocytes but rich in neutrophils w162x.
The finding that fetuses with FIRS had elevated neutrophil counts is consistent with several previous studies from our group and others. Carroll and Nicolaides w23x demonstrated that fetuses with bacteremia had higher leukocyte and neutrophil counts than those without bacteremia in patients with preterm PROM. Fetuses with FIRS also have phenotypic evidence of monocyte-neutrophil activation in patients who delivered within 72 hours of cordocentesis w12x. Moreover, umbilical cord blood from patients with acute funisitis, the histological counterpart of FIRS w122x, had phenotypic and metabolic changes on leukocytes (higher median mean chan- nel brightness of CD14, CD64, and CD66b on granulocytes and of CD64 on monocytes and increased basal intracellular reactive oxygen species and oxidative burst in monocytes) w79x. These findings suggest that fetuses with FIRS had a hematologic profile consistent with activation of the innate limb of the immune response.
More than two-thirds of fetuses with FIRS had neutrophilia, and only 4.8% had neutropenia. These observations seem to contradict the findings in septic preterm neonates who frequently present with neutropenia. The mechanism of fetal neutrophilia is not completely understood. However, it has been proposed that granulocyte colony stimulating factor (G-CSF), the primary physiologic regulator of neutrophil production and emergency signal of neutrophil release, may participate in these mechanisms w11, 21, 22, 35, 116x. Indeed, fetuses with FIRS had higher plasma concentrations of G-CSF than those without FIRS w11x. It is possible that fetal infection causes elevation of G-CSF and mobilization of neutrophils from bone marrow, resulting in fetal neutrophilia. Subsequently, the neutrophil storage pool in these fetuses is depleted, and the neonates become neutropenic after birth. This hypothesis is consistent with a chronic nature of infection-related preterm birth w14, 28, 54, 69, 94, 114, 133, 152, 171, 180, 190x. Erythropoiesis and NRBC count in FIRS Erythropoiesis, a process of red blood cell production, is a component of hematopoiesis, which is crucial from a developmental perspective. The development of an erythropoietic system allows growth of the higher organisms to a size not otherwise possible due to inadequate supply of oxygen by simple diffusion, a key mechanism for oxygen transport in lower organisms w30x. Humans have four principal sites of erythropoiesis: yolk sac, ventral aspect of the aorta, liver, and bone marrow. Hepatic hematopoiesis diminishes with advancing gestational age, the bone marrow becomes the primary site of erythropoiesis w125x. The main regulator of this process is erythropoietin. This growth factor maintains red blood cell production during fetal, neonatal, and adult life by inhibiting apoptosis of erythroid progenitors and by stimulating their proliferation and differentiation into normoblasts.
In contrast to adults, the primary source of erythropoietin in fetal life is the liver, and it is not until approximately the 30 th week of gestation that renal erythropoietin production begins w30, 125x. This hematopoietic factor can be stimulated by hypoxia-inducible factors -1 and -2, IL-6, and tumor necrosis factor-a. Elevated erythropoietin has been reported in several pathologic conditions such as hypoxia w48, 91, 132x, anemia w172, 185x, placental insufficiency w48, 74x, or infants of diabetic mothers w169, 181x. In these conditions, erythropoietin is correlated with an elevated NRBC count in umbilical cord blood w47, 93x. Recently, the administration of recombinant erythropoietin to mothers or fetuses ameliorated the fetal liver and white matter injury in endotoxin treated animals w37, 82x.
Fetuses with FIRS tend to have higher NRBC counts
than those without FIRS One of the principal findings of this study is that the fetuses with FIRS had a higher absolute NRBC count than those without FIRS. However, when NRBC counts were adjusted for gestational age, the difference fell short of reaching statistical significance (Ps0.06). Since NRBC counts in this study were expressed as numbers of NRBC per 100 WBC, the real magnitude of the changes in NRBC counts observed herein may have been underestimated. The increase in the total leukocyte count in FIRS may artificially lead to an underestimation of the number of NRBCs when using this ratio.
Elevated neonatal NRBC counts have been reported in patients with prolonged rupture of fetal membranes ()24 h) w96x, histologic chorioamnionitis w87x, high acute placental inflammation score w153x, and early-onset neonatal sepsis w40x. Since we have reported that FIRS is not associated with changes in the umbilical vein blood gas pH and PaO 2 w57x, hypoxia and metabolic acidosis are unlikely to cause the increased erythropoiesis observed herein. We propose that the increased number of NRBC represents the action of selected cytokines such as IL-6.
IL-6 and fetal hematopoiesis IL-6 is a cytokine with a broad range of biological activities produced by macrophages, T cells, and B cells w75, 136x. This cytokine is a major mediator of the host response to infection and tissue damage that plays a central role in the defense mechanism, acute phase reaction, and hematopoiesis w75, 136x. Studies in animals w173x and humans w166x indicate that IL-6 can stimulate erythropoiesis. Intrauterine administration of endotoxin to pregnant mice increases circulating NRBC in the fetal blood without significant elevations in erythropoietin concentrations w44x. Therefore, we propose that an elevated IL-6 in FIRS is responsible, at least in part, for the increased erythropoiesis reflected in the NRBC count.
Alternatively, the effect of IL-6 may be indirect. This cytokine can stimulate erythropoietin production and, through this mechanism, indirectly increase NRBC count. Evidence in support of this hypothesis includes 1) umbilical venous blood erythropoietin and umbilical arterial blood IL-6 concentrations are higher in infants born to mothers with both histologic and clinical chorioamnionitis than those born to mothers without chorioamnionitis w165x; 2) neonates with acute funisitis have higher erythropoietin concentrations than those without acute funisitis w93x; and 3) in hospitalized adult patients, NRBC count is correlated with plasma erythropoietin as well as inflammation related cytokine (IL-3, IL-6, and IL-12p70) concentrations w167x. Patients with elevated NRBC counts have higher mortality rates than those with elevated erythropoietin or IL-6 concentration alone. Stachon et al. w167x proposed that the NRBC count may be considered as a parameter that expresses the combined effects of hypoxia (erythropoietin) and inflammation (IL-6).
Strength and limitations of the study
This is the first study describing the hematologic profiles of human fetuses with FIRS. The limitations of this study are the following: 1) a subset of patients received medication including antenatal steroids, tocolysis, and antibiotics before the procedure. However, there was no significant difference in the frequency of these confounders between fetuses with and without FIRS; and 2) the NRBC count in the current study was reported as NRBC per 100 WBC. This parameter has been criticized as being susceptible to underestimation or overestimation of the absolute value of NRBC, especially in conditions where there is an increase or decrease in leukocyte counts, respectively w71x. Even if we wished to report the results as absolute numbers of NRBC per unit volume, an accurate adjustment of NRBC counts as a function of gestational age cannot be performed because there is no published reference standard for gestational age for the absolute number of NRBC per unit volume (e.g., cells/mm 3 or cells/L) available.
Conclusion
The hematologic profile of the fetus with FIRS is characterized by significant changes in the total WBC and neutrophil counts. The NRBC count in fetuses with FIRS tends to be higher than that of fetuses without FIRS, and this cannot be attributed to the effect of hypoxia. In contrast to septic preterm neonates, the majority of fetuses with FIRS have neutrophilia. This study contributes to characterizing the hematologic parameters in fetuses with FIRS. 
